≪英文≫

Dual functions of angiopoietin-like protein 2 signaling in tumor progression and anti-tumor immunity.

Horiguchi H, Kadomatsu T, Kurahashi R, Hara C, Miyata K, Baba M, Osumi H, Terada K, Araki K, Takai T, Kamba T, Linehan WM, Moroishi T, Oike Y.

Genes Dev. 2019 Dec 1;33(23-24):1641-1656.

 

Differential predictive factors for cardiovascular events in patients with or without cancer history.

Sueta D, Tabata N, Ikeda S, Saito Y, Ozaki K, Sakata K, Matsumura T, Yamamoto-Ibusuki M, Murakami Y, Jodai T, Fukushima S, Yoshida N, Kamba T, Araki E, Iwase H, Fujii K, Ihn H, Kobayashi Y, Minamino T, Yamagishi M, Maemura K, Baba H, Matsui K, Tsujita K.

Medicine (Baltimore). 2019 Nov;98(44):e17602. doi:10.1097/MD.0000000000017602.

 

Laparoscopic radical cystectomy in octogenarians: analysis of a Japanese multicenter cohort.

Ito K, Kanno T, Sawada A, Saito R, Kobayashi T, Yamada H, Inoue T, Ogawa O.

(Tanoue K and Kamba T are indicated in Acknowledgement.)

Int J Clin OncolMol. 2019 Sep;24(9):1081-1088.

 

TFE3 Xp11.2 translocation renal cell carcinoma mouse model reveals novel therapeutic targets and identifies GPNMB as a diagnostic marker for human disease.

Baba M, Furuya M, Motoshima T, Lang M, Funasaki S, Ma W, Sun HW, Hasumi H, Huang Y, Kato I, Kadomatsu T, Satou Y, Morris N, Karim BO, Ileva L, Kalen JD, Wilan Krisna LA, Hasumi Y, Sugiyama A, Kurahashi R, Nishimoto K, Oyama M, Nagashima Y, Kuroda N, Araki K, Eto M, Yao M, Kamba T, Suda T, Oike Y, Schmidt LS, Linehan WM.

Mol Cancer Res. 2019 Aug;17(8):1613-1626.

 

MiR-204-5p: a novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma.

Kurahashi R, Kadomatsu T, Baba M, Hara C, Itoh H, Miyata K, Endo M, Morinaga J, Terada K, Araki K, Eto M, Schmidt LS, Kamba T, Linehan WM, Oike Y.

Cancer Sci. 2019 Jun;110(6):1897-1908.

 

Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma.

Sugiyama Y, Yatsuda J, Murakami Y, Ito N, Yamasaki T, Mikami Y, Ogawa O, Kamba T.

Jpn J Clin Oncol. 2019 May;49(5):465-472.

 

Complications and reoperations after laparoscopic radical cystectomy in a Japanese multicenter cohort.

Kanno T, Ito K, Sawada A, Saito R, Kobayashi T, Yamada H, Inoue T, Ogawa O.

(Tanoue K and Kamba T are indicated in Acknowledgement.)

Int J Urol. 2019 Apr;26(4):493-498.

 

Clinical utility of androgen receptor gene aberrations in circulating cell-free DNA as a biomarker for treatment of castration-resistant prostate cancer.

Sumiyoshi T, Mizuno K, Yamasaki T, Miyazaki Y, Makino Y, Okasho K, Li X, Utsunomiya N, Goto T, Kobayashi T, Terada N, Inoue T, Kamba T, Fujimoto A, Ogawa O, Akamatsu S.

Sci Rep. 2019 Mar 11;9(1):4030. doi: 10.1038/s41598-019-40719-y.

 

Manipulation of Nephron-Patterning Signals Enables Selective Induction of Podocytes from Human Pluripotent Stem Cells.

Yoshimura Y, Taguchi A, Tanigawa S, Yatsuda J, Kamba T, Takahashi S, Kurihara H, Mukoyama M, Nishinakamura R.

J Am Soc Nephrol. 2019 Feb;30(2):304-321.

 

Enhancement of cancer invasion and growth via the C5a-C5a receptor system: Implications for cancer promotion by autoimmune diseases and association with cervical cancer invasion.

Yoneda M, Imamura R, Nitta H, Taniguchi K, Saito F, Kikuchi K, Ogi H, Tanaka T, Katabuchi H, Nakayama H, Imamura T.

J Am Soc Nephrol. 2019 Feb;30(2):304-321.

 

≪和文≫

腹腔鏡下膀胱全摘除術は本邦に安全に導入されたか？：本邦多施設共同研究での導入初期症例における治療成績の検討

寒野徹, 井上貴博, 伊藤克弘, 河野有香, 川西博晃, 奥村和弘, 山田仁, 久保田聖史, 川喜田睦司, 藤井将人, 寺田直樹, 賀本敏行, 清水洋祐, 伊藤哲之, 田上憲一郎, 神波大己, 小堀豪, 諸井誠司, 濵田彬弘, 増井仁彦, 七里泰正, 柴崎昇, 赤尾利弥, 澤田篤郎, 齊藤亮一, 小林恭, 小川修, 大文字会臨床データベース(Dai-CAD)

泌尿紀要. 2019;65(11):439-444.